Does Medicaid Cover Ketamine Treatment? Coverage Plans, Out-of-Pocket Costs, and Reimbursement

does medicaid cover ketamine treatment

Table of Contents

When it comes to whether Medicaid covers the cost for ketamine treatment, the short answer is, if it’s FDA-approved, then sometimes. But if the treatment method is experimental or off-label, Medicaid will most likely deny claims for insurance coverage.

Ketamine therapy is a breakthrough for depression treatment, especially for patients who did not respond to traditional treatment methods.1 However, since some aspects of ketamine treatment for depression are off-label and not FDA-approved, getting insurance coverage for the cost of the drug can be a challenge. 

If you or someone you love is struggling with depression and co-occurring disorders, Nurture Nexus Recovery Center offers medication-assisted treatment that can help!

Does Medicaid Cover Ketamine Therapy in Texas?

Texas Medicaid follows federal Medicaid guidelines while applying its own state-level coverage rules. In general, Texas Medicaid does not cover ketamine treatment when it is used off-label, which includes most IV ketamine infusions and oral ketamine prescriptions for depression.2

For most Medicaid purposes, ketamine is used as anesthesia and pain relief for chronic conditions. If your documentation supports ketamine treatment for these ailments, you may have a chance at coverage; however, experimental and off-label requests are almost always denied.

ketamine uses
Uses Of Ketamine

Understanding Medicaid Coverage for Mental Health & Addiction Treatment

Under the Affordable Care Act and Medicaid’s own policy, it can provide coverage for medical treatment for people with disabilities. Within its definition of disability, Medicaid also includes treatment for addiction and mental health, along with co-occurring disorders.

Medicaid is required to cover behavioral health and substance use disorder treatment, including outpatient mental health services, inpatient care, and medication-assisted treatment (MAT) for approved conditions. These benefits are governed by federal parity laws, which aim to ensure mental health care is treated similarly to physical health care.3

In general, Medicaid usually covers the following rehab, behavioral health, and addiction treatment services:

How Does Ketamine Fit in Medicaid Coverage Standards?

Ketamine takes a unique space in insurance policy coverage within the healthcare sector. While healthcare professionals see ketamine infusions and lozenges as a safe and sustainable breakthrough for treatment-resistant depression cases, the FDA has not approved them for such purposes.4 

This makes Medicaid and other state-funded insurance take a hardline approach against it as well. For Medicaid to approve coverage, the treatment must:

  • Be FDA-approved for the condition being treated
  • Be delivered in a controlled clinical setting
  • Follow established dosing and monitoring protocols
  • Demonstrate clear medical necessity

 

Expert Opinion on Varying Ketamine Coverage by Medicaid

“As Medicaid policies are impacted by state regulations, Ketamine treatment falls in the twilight zone of coverage. For some treatment options, such as nasal esketamine, Medicaid offers coverage in Texas as long as medical necessity requirements are met. However, experimental procedures such as Ketamine lozenges or IV drips are still undecided at a policy level. If you’re not eligible for Medicaid, explore other insurance plans or local assistance programs to ensure you get the help you deserve.”

-Dr. Taiye Popoola

Ketamine Treatment Options and Medicaid Coverage

Whether or not Medicaid will cover your ketamine therapy in Texas depends on what type of ketamine treatment is being administered and its approval status with the FDA. A general breakdown of the coverage provided includes:

Type of Treatment FDA Approval Status Typical Medicaid Coverage Administration Additional
IV Ketamine Infusion Not Approved Not Covered Through IV, at the clinic FDA does not recognize off-label use
Esketamine Approved Usually Covered Via nasal, at the clinic Requires prior authorization for coverage
Oral Ketamine Not Approved Not Covered Orally, at home It is an experimental treatment
Compounded Ketamine Not Approved Not Covered Depends on prescription Has a high denial rate in Medicaid

 

Ketamine Infusions Vs. Esketamine: What’s the Difference in Coverage?

Esketamine is a derivative of ketamine used to treat depression due to its potency and fast-acting antidepressant effects. Since 2019, it has been approved by the FDA for depression treatment under clinical settings.5

Ketamine, as discussed earlier, is administered via IV drips and injections. It is often provided multiple times a week and can have a delayed impact on mental health or addiction treatment.6

The main difference between the two in terms of coverage is:

  • Esketamine is becoming popular with Medicaid coverage in many states and is generally accepted when medical necessity is met.
  • Ketamine is not generally covered by Medicaid when administered off-label, but it may be covered by private plans. It also provides a greater risk of causing ketamine addiction.

 

Can There Be Out-Of-Pocket Costs With Ketamine Treatment?

When discussing ketamine therapy coverage at your local drug addiction treatment center, always ensure what treatment options they provide and whether it works with your Medicaid plan. 

Even when Medicaid is providing coverage for your ketamine treatment, you may incur some out-of-pocket charges, such as:

  • Evaluation fees not covered by Medicaid
  • Missed appointment charges
  • Services outside the approved treatment plan
  • Non-covered therapy components
  • Transportation to certified treatment facilities

For treatments Medicaid does not cover, such as IV ketamine infusions, patients are responsible for the full cost unless alternative financial arrangements are offered by the provider.7 Understanding these potential expenses upfront can prevent financial stress during treatment and help you make informed decisions.

 

How to Check if Medicaid Covers Ketamine for Depression

Before committing to a ketamine treatment program for depression and co-occurring disorders, you need to check with Medicaid in your state to ensure you have some coverage. You can do so by:

  1. Familiarizing Yourself With The Policy: Your first step should be to check your behavioral health treatment center’s insurance policy and how they work with Medicaid to provide coverage. 
  2. Reaching Out to Medicaid: If you are unsure about treatment coverage from the facility, you can reach out to Medicaid in your state and request a preauthorization for ketamine treatment coverage.
  3. Preparing Your Documents: Once you’ve started with your ketamine treatment, you must keep all your documents in order and ensure they show medical necessity.8 That way, if regulations regarding ketamine coverage change during long-term treatment, you have a strong case for coverage.
  4. Find the Middle Ground: In some cases, Medicaid will not cover ketamine treatment but will provide coverage for associated psychotherapy and addiction treatment services. This can bring your overall cost of treatment down, even if it doesn’t cover everything.

Nurture Nexus Recovery Center Accepts Medicaid Insurance Across Texas

Whether you’re undergoing ketamine treatment for depression or for addiction treatment, Nurture Nexus Recovery Center helps you understand the extent of your Medicaid coverage. Our medication-assisted treatment programs rely on FDA-approved treatment methods and additional reinforcement through psychotherapy and behavioral health approaches.

Our treatment programs are fully insured, so verify your insurance before moving forward to check your coverage. Call us today at (214) 838-7488 or contact us to book an appointment. 

People Also Ask

Is It Possible to Get an Addiction From Ketamine Treatment?

Although the dosage of ketamine in treatment and therapy is low, some individuals may develop an addiction if they abuse their medication to consume ketamine in large quantities.

Will Ketamine Coverage Regulations Change in the Future?

As Ketamine therapy grows in popularity and continues to show consistent results, medical experts believe policy changes may occur soon, and Ketamine may be included in overall Medicaid coverage in the future. In some states, this change has already begun, yet it hasn’t introduced on a federal level.

Why Doesn’t the FDA Approve Ketamine Drips for Depression and Addiction Treatment?

Ketamine infusions for depression and addiction treatment are an experimental area that isn’t approved by the FDA due to the potential risks of ketamine use. However, as treatment continues to prove successful, the future may perhaps see it approved.

Additional Resources

  1. Top 5 Ways to Stage Intervention For Ketamine Addiction
  2. How to Find Drug Rehab Facilities Near Me That Accept Medicaid
  3. Your Ultimate Guide to Addiction Treatment in San Antonio, Texas
  4. Finding Alcohol Rehabs That Take Medicaid Near You In Texas
  5. How To Find The Best Drug Rehab Centers in El Paso
ketamine therapy
Get Addiction Treatment With Ketamine Therapy!
  1. Liu H, Wu X, Chen J, Fang Y. A Breakthrough in Understanding the Rapid Antidepressant Effect of Ketamine Based on Structural Analysis. Neuroscience Bulletin [Internet]. 2021 Nov 16 [cited 2026 Jan 8];38(2):229–31. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8821759/
  2. Barnett BS, Guest columnist: Formulary Coverage of Esketamine and Ketamine for Depression in Ohio Health Insurance Marketplace and Medicaid Plans. Journal of Psychiatric Practice [Internet]. 2024 Mar 1 [cited 2026 Jan 8];30(2):130–3. Available from: https://pubmed.ncbi.nlm.nih.gov/38526400/
  3. Breslau J, Han B, Lai J, Yu H. Impact of the Affordable Care Act Medicaid Expansion on Utilization of Mental Health Care. Medical Care [Internet]. 2020 Jul 23 [cited 2026 Jan 8];58(9):757–62. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7483910/
  4. McInnes LA, Marton TF, Qian JJ. Embracing pragmatism for ketamine insurance coverage: Leveraging real-world evidence. Journal of Affective Disorders [Internet]. 2024 May [cited 2026 Jan 8];352(1):199–200. Available from: https://pubmed.ncbi.nlm.nih.gov/38350540/
  5. Drug Enforcement Administration. Ketamine [Internet]. Drug Enforcement Administration. 2020 Apr [cited 2026 Jan 8]. Available from: https://www.dea.gov/sites/default/files/2020-06/Ketamine-2020.pdf
  6. Piotr Kawczak, Igor Feszak, Tomasz Bączek. Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms. Biomedicines [Internet]. 2024 Oct 9 [cited 2026 Jan 8];12(10):2283–3. Available from: https://www.mdpi.com/2227-9059/12/10/2283
  7. Elmosalamy A, Idil Tarikogullari, Patarroyo-Rodriguez L, Wilson G, Vande JL, Kung S, et al. Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology [Internet]. 2025 Nov 1 [cited 2026 Jan 8];15(1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12615959/
  8. Aslam AM, Shinozuka K, Muir O, Tabaac BJ. Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends. American journal of therapeutics [Internet]. 2025 [cited 2026 Jan 8];32(3):242–6. Available from: https://pubmed.ncbi.nlm.nih.gov/40338681/
  1. Liu H, Wu X, Chen J, Fang Y. A Breakthrough in Understanding the Rapid Antidepressant Effect of Ketamine Based on Structural Analysis. Neuroscience Bulletin [Internet]. 2021 Nov 16 [cited 2026 Jan 8];38(2):229–31. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8821759/
  2. Barnett BS, Guest columnist: Formulary Coverage of Esketamine and Ketamine for Depression in Ohio Health Insurance Marketplace and Medicaid Plans. Journal of Psychiatric Practice [Internet]. 2024 Mar 1 [cited 2026 Jan 8];30(2):130–3. Available from: https://pubmed.ncbi.nlm.nih.gov/38526400/
  3. Breslau J, Han B, Lai J, Yu H. Impact of the Affordable Care Act Medicaid Expansion on Utilization of Mental Health Care. Medical Care [Internet]. 2020 Jul 23 [cited 2026 Jan 8];58(9):757–62. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7483910/
  4. McInnes LA, Marton TF, Qian JJ. Embracing pragmatism for ketamine insurance coverage: Leveraging real-world evidence. Journal of Affective Disorders [Internet]. 2024 May [cited 2026 Jan 8];352(1):199–200. Available from: https://pubmed.ncbi.nlm.nih.gov/38350540/
  5. Drug Enforcement Administration. Ketamine [Internet]. Drug Enforcement Administration. 2020 Apr [cited 2026 Jan 8]. Available from: https://www.dea.gov/sites/default/files/2020-06/Ketamine-2020.pdf
  6. Piotr Kawczak, Igor Feszak, Tomasz Bączek. Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms. Biomedicines [Internet]. 2024 Oct 9 [cited 2026 Jan 8];12(10):2283–3. Available from: https://www.mdpi.com/2227-9059/12/10/2283
  7. Elmosalamy A, Idil Tarikogullari, Patarroyo-Rodriguez L, Wilson G, Vande JL, Kung S, et al. Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology [Internet]. 2025 Nov 1 [cited 2026 Jan 8];15(1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12615959/
  8. Aslam AM, Shinozuka K, Muir O, Tabaac BJ. Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends. American journal of therapeutics [Internet]. 2025 [cited 2026 Jan 8];32(3):242–6. Available from: https://pubmed.ncbi.nlm.nih.gov/40338681/